About the University of Chicago Cancer Center
The University of Chicago Cancer Center (UCCC) was founded in 1973 as a Comprehensive Cancer Center (CCC) within the University of Chicago Medical Center in Chicago, Illinois.
The facility is one of 47 CCCs across the country designated by the National Cancer Institute (NCI) in the United States.
The UCCC’s Comprehensive Cancer Center designation means it’s recognized as a highly equipped research facility that applies new and novel treatments. All CCCs share a common goal — to use laboratory and prevention research with clinical trials to treat cancers.
As one of the two CCCs in Illinois, the facility has earned a reputation for innovation and excellence.
The UCCC is located near Washington Park, in Chicago, Illinois at:
5814 S Maryland Ave. MC 1140, H212
Chicago, IL, 60637
Leadership at the University of Chicago Cancer Center
With the help of a collaborative research program comprised of more than 200 distinguished researchers and physicians, UCCC has emerged as a leading cancer treatment center.
The first director of the facility was John Ultmann, who specialized in diagnosing, staging and treating Hodgkin’s disease and non-Hodgkin’s lymphoma, along with developing chemotherapy treatment.
The current director is Michelle Le Beau, who has helped the facility expand the scope of research programs and launch a comprehensive community engagement program.
The program is focused on increasing public awareness around cancer prevention, detection, treatment and the role of genes in cancer development.
A deep commitment to research and clinical trials paired with a long list of specialized physicians and researchers has enabled UCCC to bring cancer patients new hope.
Individuals diagnosed with mesothelioma can expect the highest quality of care if they choose to seek treatment at UCCC.